These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Large and small airway responses to procaterol hydrochloride administered through different extension devices in asthmatic patients. Fontana GA; Lavorini F; Chiostri M; Castellani W; Boddi V; Pistolesi M J Aerosol Med; 1999; 12(3):177-85. PubMed ID: 10623334 [TBL] [Abstract][Full Text] [Related]
25. Aerosol therapy: the special needs of young children. Janssens HM; Tiddens HA Paediatr Respir Rev; 2006; 7 Suppl 1():S83-5. PubMed ID: 16798606 [TBL] [Abstract][Full Text] [Related]
26. General factors influencing drug delivery to the lung. Ganderton D Respir Med; 1997 Nov; 91 Suppl A():13-6. PubMed ID: 9474361 [TBL] [Abstract][Full Text] [Related]
27. Implementation of a Policy Change: Replacement of Nebulizers by Spacers for the Treatment of Asthma in Children. Breuer O; Shoseyov D; Kerem E; Brooks R Isr Med Assoc J; 2015 Jul; 17(7):421-4. PubMed ID: 26357717 [TBL] [Abstract][Full Text] [Related]
28. Effect of an aerosol delivery system on bronchodilator activity. Crimi N; Palermo F; Cacopardo B; Vancheri C; Oliveri R; Polosa R; Mistretta A Ann Allergy; 1989 Jan; 62(1):26-9. PubMed ID: 2912322 [TBL] [Abstract][Full Text] [Related]
29. The change to non-CFC metered dose inhalers. Rubinfeld A Aust Fam Physician; 1997 Dec; 26(12):1412-4. PubMed ID: 9470296 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and safety of inhalation therapy in chronic obstructive pulmonary disease and asthma. Pavia D Respirology; 1997; 2 Suppl 1():S5-10. PubMed ID: 9400688 [TBL] [Abstract][Full Text] [Related]
32. Oropharyngeal deposition and delivery aspects of metered-dose inhaler aerosols. Kim CS; Eldridge MA; Sackner MA Am Rev Respir Dis; 1987 Jan; 135(1):157-64. PubMed ID: 3800143 [TBL] [Abstract][Full Text] [Related]
33. Inhalation treatment: errors in application and difficulties in acceptance of the devices are frequent in wheezy infants and young children. Marguet C; Couderc L; Le Roux P; Jeannot E; Lefay V; Mallet E Pediatr Allergy Immunol; 2001 Aug; 12(4):224-30. PubMed ID: 11555320 [TBL] [Abstract][Full Text] [Related]
34. The adult patient's difficulties with inhalers. Crompton GK Lung; 1990; 168 Suppl():658-62. PubMed ID: 2117176 [TBL] [Abstract][Full Text] [Related]
35. The clinical relevance of dry powder inhaler performance for drug delivery. Demoly P; Hagedoorn P; de Boer AH; Frijlink HW Respir Med; 2014 Aug; 108(8):1195-203. PubMed ID: 24929253 [TBL] [Abstract][Full Text] [Related]
36. Inhaler and spacer use in obstructive airway diseases. Jones MD; Yeager H Am Fam Physician; 1990 Oct; 42(4):1007-13. PubMed ID: 2220509 [TBL] [Abstract][Full Text] [Related]
38. Does parental involvement in pediatric emergency department asthma treatment affect home management? Hussain-Rizvi A; Kunkov S; Crain EF J Asthma; 2009 Oct; 46(8):792-5. PubMed ID: 19863282 [TBL] [Abstract][Full Text] [Related]
39. Aerosol devices in the treatment of asthma. Technical and clinical factors. Rubinfeld A Aust Fam Physician; 1992 Sep; 21(9):1300-1, 1304, 1307-8. PubMed ID: 1417559 [TBL] [Abstract][Full Text] [Related]